Payment Pressures in U.S. Specialty: Status quo and outlook for future financing On-Demand Webinar 美国特定的付款压力:现状和未来融资前景 To allow for the optimal positioning of your product, portfolio, or company, it is critical…Certara2020 年 9 月 15 日
New Pinnacle 21 Community Validation Engine: FDA (1907.2) Announcement New Pinnacle 21 Community Validation Engine: FDA (1907.2) In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…Certara2020 年 9 月 13 日
Secondary Intelligence Fact Sheet Secondary Intelligence 预测脱靶风险,简化次级药效学(Secondary Pharmacology)分析,提高药物开发的安全性。Certara2020 年 9 月 4 日
Exploring Common CDISC ADaM Dataset Conformance Findings On-Demand Webinar Exploring Common CDISC ADaM Dataset Conformance Findings What you need to know when validating your CDISC ADAM datasets During the regulatory review…Certara2020 年 9 月 3 日
Clinical trials of disease stages in COVID 19: complicated and often misinterpreted Publication Clinical trials of disease stages in COVID 19: complicated and often misinterpreted As of 2020 年 7 月 28 日, 1840 clinical trials were registered globally, with 1001 clinical trials…Certara2020 年 8 月 22 日
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 Publication Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…Certara2020 年 8 月 22 日
Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China Blog Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…Certara2020 年 8 月 7 日
Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Publication Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…Certara2020 年 7 月 26 日